Cite

    Heba Nashat et al.. “A single-centre, placebo-controlled, double-blind randomised cross-over study of nebulised iloprost in patients with Eisenmenger syndrome: A pilot study.” International journal of cardiology, vol. 299, 2020, pp. 131–135. http://access.bl.uk/ark:/81055/vdc_100098053389.0x000050